Amundi
ASMB icon

Amundi’s Assembly Biosciences ASMB Stock Holding History

Amundi’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,934
Closed -$114K – 2148
2024
Q3 		$114K Hold
7,934
– – ﹤0.01% 1761
2024
Q2 		$96.4K Hold
7,934
– – ﹤0.01% 1713
2024
Q1 		$106K Hold
7,934
– – ﹤0.01% 1755
2023
Q4 		$78.2K Buy
+7,934
New +$75.4K ﹤0.01% 1823

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi's ASMB Position: Q4 2024 in Review

Amundi sold out of Assembly Biosciences (ASMB) in Q4 2024, closing a stake of 7,934 shares — an estimated $114K sold.

Amundi first reported a position in ASMB in Q4 2023 and held it in 4 quarters. The position peaked at $114K in Q3 2024. 35 funds tracked by Wall St. Rank hold ASMB as of Q4 2024.

  • Amundi reported no remaining Assembly Biosciences position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 7,934 Assembly Biosciences shares in Q4 2024, an estimated $114K.
  • Amundi first reported a position in Assembly Biosciences in Q4 2023 and held it in 4 quarters.
  • Amundi's Assembly Biosciences position peaked at $114K in Q3 2024.
  • 35 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.